24-Week beta-alanine ingestion does not affect muscle taurine or clinical blood parameters in healthy males

Imagem de Miniatura
Arquivos
art_SAUNDERS_24Week_betaalanine_ingestion_does_not_affect_muscle_taurine_2020.PDF.pdf (806.17 KB)
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2020
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER HEIDELBERG
Autores
FRANCHI, Mariana
SILVA, Vinicius da Eira
PAINELLI, Vitor de Salles
COSTA, Luiz Augusto Riani
SALE, Craig
HARRIS, Roger Charles
Citação
EUROPEAN JOURNAL OF NUTRITION, v.59, n.1, p.57-65, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Purpose To investigate the effects of chronic beta-alanine (BA) supplementation on muscle taurine content, blood clinical markers and sensory side-effects. Methods Twenty-five healthy male participants (age 27 +/- 4 years, height 1.75 +/- 0.09 m, body mass 78.9 +/- 11.7 kg) were supplemented with 6.4 g day(-1) of sustained-release BA (N = 16; CarnoSyn (TM), NAI, USA) or placebo (PL; N = 9; maltodextrin) for 24 weeks. Resting muscle biopsies of the m. vastus lateralis were taken at 0, 12 and 24 weeks and analysed for taurine content (BA, N = 12; PL, N = 6) using high-performance liquid chromatography. Resting venous blood samples were taken every 4 weeks and analysed for markers of renal, hepatic and muscle function (BA, N = 15; PL, N = 8; aspartate transaminase; alanine aminotransferase; alkaline phosphatase; lactate dehydrogenase; albumin; globulin; creatinine; estimated glomerular filtration rate and creatine kinase). Results There was a significant main effect of group (p = 0.04) on muscle taurine, with overall lower values in PL, although there was no main effect of time or interaction effect (both p > 0.05) and no differences between specific timepoints (week 0, BA: 33.67 +/- 8.18 mmol kg(-1) dm, PL: 27.75 +/- 4.86 mmol kg(-1) dm; week 12, BA: 35.93 +/- 8.79 mmol kg(-1) dm, PL: 27.67 +/- 4.75 mmol kg(-1) dm; week 24, BA: 35.42 +/- 6.16 mmol kg(-1) dm, PL: 31.99 +/- 5.60 mmol kg(-1) dm). There was no effect of treatment, time or any interaction effects on any blood marker (all p > 0.05) and no self-reported side-effects in these participants throughout the study. Conclusions The current study showed that 24 weeks of BA supplementation at 6.4 g day(-1) did not significantly affect muscle taurine content, clinical markers of renal, hepatic and muscle function, nor did it result in chronic sensory side-effects, in healthy individuals. Since athletes are likely to engage in chronic supplementation, these data provide important evidence to suggest that supplementation with BA at these doses for up to 24 weeks is safe for healthy individuals.
Palavras-chave
Chronic beta-alanine supplementation, Muscle taurine, Clinical markers, Safety, Side-effects
URI
https://observatorio.fm.usp.br/handle/OPI/35575
Referências
  1. BAKARDJIEV A, 1994, EUR J BIOCHEM, V225, P617, DOI 10.1111/j.1432-1033.1994.00617.x
  2. BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787
  3. Blancquaert L, 2017, MED SCI SPORT EXER, V49, P602, DOI 10.1249/MSS.0000000000001213
  4. Blancquaert L, 2016, J PHYSIOL-LONDON, V594, P4849, DOI 10.1113/JP272050
  5. Church DD, 2017, J AM COLL NUTR, V36, P608, DOI 10.1080/07315724.2017.1335250
  6. Crozier RA, 2007, J NEUROSCI, V27, P4492, DOI 10.1523/JNEUROSCI.4932-06.2007
  7. Dawson R, 2002, AMINO ACIDS, V22, P309
  8. Decombaz J, 2012, AMINO ACIDS, V43, P67, DOI 10.1007/s00726-011-1169-7
  9. del Favero S, 2012, AMINO ACIDS, V43, P49, DOI 10.1007/s00726-011-1190-x
  10. Dunnett M, 1997, RES VET SCI, V62, P213, DOI 10.1016/S0034-5288(97)90192-2
  11. Dunnett M, 1997, J CHROMATOGR B, V688, P47, DOI 10.1016/S0378-4347(97)88054-1
  12. Everaert I, 2013, EUR J APPL PHYSIOL, V113, P1169, DOI 10.1007/s00421-012-2540-4
  13. Everaert I, 2013, MED SCI SPORT EXER, V45, P43, DOI 10.1249/MSS.0b013e31826cdb68
  14. Galloway SDR, 2008, J APPL PHYSIOL, V105, P643, DOI 10.1152/japplphysiol.90525.2008
  15. Hamilton EJ, 2006, AMINO ACIDS, V31, P273, DOI 10.1007/s00726-006-0291-4
  16. Harris RC, 1998, J SPORT SCI, V16, P639
  17. Harris RC, 2006, AMINO ACIDS, V30, P279, DOI 10.1007/s00726-006-0299-9
  18. Harris RC, 2010, MED SCI SPORT EXER, V42, P107, DOI 10.1249/01.MSS.0000385977.18201.74
  19. Hill CA, 2007, AMINO ACIDS, V32, P225, DOI 10.1007/s00726-006-0364-4
  20. Hobson RM, 2012, MED SCI SPORT EXER, V44, P446
  21. Ito T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107409
  22. Kelly VG, 2017, J SCI MED SPORT, V20, P12, DOI 10.1016/j.jsams.2016.06.006
  23. Maughan RJ, 2018, BRIT J SPORT MED, V52, P439, DOI 10.1136/bjsports-2018-099027
  24. Neves M, 2012, SCAND J MED SCI SPOR, V22, P175, DOI 10.1111/j.1600-0838.2010.01264.x
  25. Ripps H, 2012, MOL VIS, V18, P2673
  26. Saunders B, 2017, MED SCI SPORT EXER, V49, P896, DOI 10.1249/MSS.0000000000001173
  27. Saunders B, 2017, BRIT J SPORT MED, V51, P658, DOI 10.1136/bjsports-2016-096396
  28. Saunders B, 2013, J SCI MED SPORT, V16, P286, DOI 10.1016/j.jsams.2012.07.004
  29. Schaffer SW, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S2
  30. Stellingwerff T, 2012, AMINO ACIDS, V42, P2461, DOI 10.1007/s00726-011-1054-4
  31. Tallon MJ, 2007, BIOGERONTOLOGY, V8, P129, DOI 10.1007/s10522-006-9038-6
  32. Varanoske AN, 2019, AMINO ACIDS, V51, P49, DOI 10.1007/s00726-018-2609-4
  33. Varanoske AN, 2017, NUTR RES, V48, P16, DOI 10.1016/j.nutres.2017.10.002
  34. Warskulat U, 2004, FASEB J, V18, P577, DOI 10.1096/fj.03-0496fje

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - LIM/17